infohep
  • Menu
  • Search
  • Home
  • News
  • About hepatitis
  • Countries
  • About us
  • Twitter
  • Facebook
  • RSS
  • Home
  • News
  • All the news

All the news

Showing 10 of 20 articles from: Side effects

Get an RSS feed of these articles

  • All news
  • infohep news
  • Editors' picks from other sources
  • Direct-Acting Antivirals Don't Increase Adverse Events in Hepatitis C Treatment

    MD Magazine / 18 June 2019

  • Pilot study finds HCV treatment safe in pregnancy

    Healio / 11 March 2019

  • Do Patients with Chronic Liver Disease Face Higher Drug-Induced Liver Injury Risk?

    MedPage Today / 14 November 2018

  • Optimism About HCV Treatment Comes With Caveats

    Medscape / 22 March 2017

  • HCV Drugs May Reactivate HBV, FDA Warns

    Medscape (free registration required) / 06 October 2016

  • New hepatitis C treatments cause adverse effects in the elderly

    Medscape (requires free registration) / 21 March 2016

  • Women with HCV postmenopause may experience insulin resistance

    Healio Hepatology / 26 January 2016

  • Viekira Pak, Technivie May Up Serious Liver Injury Risk: FDA

    Medscape / 23 October 2015

  • Adding ribavirin to Harvoni for hepatitis C increases side effects but not efficacy

    HIVandHepatitis.com / 29 June 2015

  • Deaths of Japanese patients prompt label change for simeprevir

    HCP Live / 24 November 2014

← First12Next →
Other pages in this section
  • Latest news
  • All the news
    • Hepatitis A
    • Hepatitis B
    • Hepatitis C
      • Transmission and prevention
      • Diagnosis and monitoring
      • Disease course and symptoms
      • HCV and coinfections
      • Living with HCV
      • Treatment issues
      • Side effects
      • Therapies
      • Liver transplants
    • Hepatitis D
    • Hepatitis E
    • Coronavirus
    • NAFLD
    • Treatment for hepatocellular carcinoma
    • Transmission, epidemiology and prevention
    • Health services, policy and advocacy
    • Social issues
  • Conference news
  • Noticeboard
  • Email bulletins
  • News feeds

  • Contact us
  • Terms and conditions
  • Accessibility
  • Privacy and cookies

Latest hepatitis news

Sign-up for our monthly email bulletin Follow us on Twitter Find us on Facebook

The information on this website is intended to support, rather than replace, consultation with a healthcare professional.

©NAM Publications 2022. All rights reserved. We are not responsible for the content of external websites.

Company limited by guarantee. Registered in England & Wales, number: 2707596. Registered charity, number: 1011220

Infohep has been supported by a grant from Gilead Sciences Europe Ltd. Our funder has had no editorial control over the site’s content.

infohep

Latest treatment news and information for patient advocates and people working in hepatitis in Europe.

infohep is produced by NAM. Find out more about NAM

www.infohep.org/page//about-us/Find-out-about-NAM/page/2626330//